Figure 1
Serotype distribution of macrolide-resistant nasopharyngeal pneumococcal isolates and percentage of attendees age-appropriately vaccinated with PCV7 at the time of surveillance.
Figure 1 | BMC Infectious Diseases
Serotype distribution of macrolide-resistant nasopharyngeal pneumococcal isolates and percentage of attendees age-appropriately vaccinated with PCV7 at the time of surveillance.